天辰生物医药(苏州)有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners 2024-09-24 21:00
Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024 2024-04-16 02:00
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD 2024-03-12 20:00
Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024 2024-02-26 02:00
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at JSA2023 2023-10-23 12:27
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023 2023-06-20 21:00
1